196 related articles for article (PubMed ID: 1156040)
1. A benzodioxanhydroxyethylpiperidine derivative with an acute central hypotensive action, different from that of clonidine. A comparison with neuroleptic agents.
Van Zwieten PA
Arch Int Pharmacodyn Ther; 1975 May; 215(1):104-18. PubMed ID: 1156040
[TBL] [Abstract][Full Text] [Related]
2. Interaction between centrally acting hypotensive drugs and tricyclic antidepressants.
van Zwieten PA
Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):12-30. PubMed ID: 1156022
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive properties of benzodioxane derivatives structurally related to R 28935. Comparison of activity with some receptor affinities.
Timmermans PB; Slothorst-Grisdijk FP; van Kemenade JE; Schoop AM; Batink HD; van Zwieten PA
Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):321-34. PubMed ID: 6280629
[TBL] [Abstract][Full Text] [Related]
4. Unusual mechanism of hypotensive activity exerted by erytrho-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET-a1-4-piperidyl)-2-benzimidazolinone (R 28935).
Wellens D; De Wilde A; van Bogaert A; van Bogaert PP; Wouters L; Reneman RS; Janssen PA
Arch Int Pharmacodyn Ther; 1975 May; 215(1):91-103. PubMed ID: 1156047
[TBL] [Abstract][Full Text] [Related]
5. Centrally induced hypotension unreleated to alpha-adrenergic stimulation.
Wellens S; Van Nueten JM; Janssen PA
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):334-7. PubMed ID: 238482
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).
Wellens D; Snoeckx L; De Reese R; Kruger R; Van de Water A; Woutens L; Reneman RS
Arch Int Pharmacodyn Ther; 1975 May; 215(1):119-32. PubMed ID: 1156041
[TBL] [Abstract][Full Text] [Related]
7. Central hypotensive and antihypertensive activities of imidazolidines, structurally related to clonidine.
Timmermans PB; Van Zwieten PA
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):251-67. PubMed ID: 921415
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of R 28935- and R 29814-induced hypotension by prazosin in anaesthetized normotensive rats.
Timmermans PB; Slothorst-Grisdijk FP; Kwa HY; van Zwieten PA
Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):309-20. PubMed ID: 7073408
[TBL] [Abstract][Full Text] [Related]
9. Centrally induced impairment of the hypotensive effects of R 28935 and R 29814 by prazosin in anaesthetized cats.
Timmermans PB; Van Zwieten PA
Eur J Pharmacol; 1980 Feb; 61(4):385-8. PubMed ID: 7053064
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
11. A centrally acting antihypertensive agent (R28935) not mediated via central alpha-adrenoreceptors.
Finch L
Eur J Pharmacol; 1975; 33(2):409-12. PubMed ID: 1183486
[TBL] [Abstract][Full Text] [Related]
12. The interaction between clonidine and various neuroleptic agents and some benzodiazepine tranquillizers.
van Zwieten PA
J Pharm Pharmacol; 1977 Apr; 29(4):229-34. PubMed ID: 17673
[TBL] [Abstract][Full Text] [Related]
13. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity.
Cosnier D; Hache J; Labrid C; Streichenberger G
Arzneimittelforschung; 1975; 25(12):1926-33. PubMed ID: 3186
[TBL] [Abstract][Full Text] [Related]
15. An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan.
Tibiriça E; Feldman J; Mermet C; Gonon F; Bousquet P
J Pharmacol Exp Ther; 1991 Feb; 256(2):606-13. PubMed ID: 1671597
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of centrally acting hypotensive drugs.
van Zwieten PA
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):13S-20S. PubMed ID: 6104975
[TBL] [Abstract][Full Text] [Related]
17. Proceedings: The effects of hypothalamic and reflexogenic hypertension on renal and femoral circulation.
Wellens D; Bogaert A; DeWilde A; Wouters L; Bogaert PP; Reneman RS
Arch Int Physiol Biochim; 1975 Feb; 83(1):144-8. PubMed ID: 50778
[TBL] [Abstract][Full Text] [Related]
18. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
[TBL] [Abstract][Full Text] [Related]
19. Central hypotensive activity of ketanserin in cats.
van Zwieten PA; Mathy MJ; Boddeke HW; Doods HN
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S54-8. PubMed ID: 2446072
[TBL] [Abstract][Full Text] [Related]
20. Deviating central hypotensive activity of urapidil in the cat.
van Zwieten PA; Mathy MJ; Thoolen MJ
J Pharm Pharmacol; 1985 Nov; 37(11):810-1. PubMed ID: 2867163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
